Skip to content

Press Releases

Filter Releases

Albireo to Host Conference Call and Webcast on March 14 at 8:30 a.m. ET to Discuss Year-End 2016 Financial Results and Operational Highlights

Mar 7, 2017

BOSTON, March 07, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), an orphan pediatric liver disease company developing novel bile acid modulators, today announced that it will host a conference call and live audio webcast on Tuesday, March 14, 2017, at 8:30 a.m. ET to discuss its financial results for the year ended December 31, 2016...
Page: First Previous Next Last

Albireo Homepage